ASX:4DXHealthcare Services
Assessing 4DMedical’s Valuation After New GSK Contract And Rising Interest In Lung Imaging Technologies
4DMedical (ASX:4DX) is back in focus after securing a one year contract with GlaxoSmithKline to supply quantitative lung imaging analytics for pulmonary drug development, while its respiratory imaging technologies draw heightened investor attention.
See our latest analysis for 4DMedical.
The GSK contract has arrived at a time when momentum around the stock is shifting again, with the share price up 8.88% in the last day and 29.91% over the week, but down 34.12% over 30 days, while very large...